BURLINGTON, N.C.--(Business Wire)--
Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today
announced that William B. (Brad) Hayes, Executive Vice President and Chief
Financial Officer, is scheduled to speak at the Credit Suisse 18th Annual
Healthcare Conference in Phoenix AZ. LabCorp`s presentation is planned for
Friday, November 13, 2009 at 9:30 a.m. (Mountain Standard Time).
A live audio webcast of the presentation will be available via the Company Web
site at www.labcorp.com and archived for replay.
About LabCorp®
Laboratory Corporation of America® Holdings, an S&P 500 company, is a pioneer in
commercializing new diagnostic technologies and the first in its industry to
embrace genomic testing. With annual revenues of $4.5 billion in 2008, over
28,000 employees worldwide, and more than 220,000 clients, LabCorp offers
clinical assays ranging from routine blood analyses to HIV and genomic testing.
LabCorp combines its expertise in innovative clinical testing technology with
its Centers of Excellence: The Center for Molecular Biology and Pathology,
National Genetics Institute, ViroMed Laboratories, Inc., The Center for Esoteric
Testing, Litholink Corporation, DIANON Systems, Inc., US LABS, Monogram
Biosciences, Inc. and Esoterix and its Colorado Coagulation, Endocrine Sciences,
and Cytometry Associates laboratories. LabCorp conducts clinical trial testing
through its Esoterix Clinical Trials Services division. LabCorp clients include
physicians, government agencies, managed care organizations, hospitals, clinical
labs, and pharmaceutical companies. To learn more about our organization, visit
our Web site at: www.labcorp.com.
This press release contains forward-looking statements. Each of the
forward-looking statements is subject to change based on various important
factors, including without limitation, competitive actions in the marketplace
and adverse actions of governmental and other third-party payors.Actual results
could differ materially from those suggested by these forward-looking
statements. Further information on potential factors that could affect LabCorp`s
financial results is included in the Company`s Form 10-K for the year ended
December 31, 2008, and subsequent SEC filings.
Laboratory Corporation of America® Holdings
Investor/Media Contact:
Stephen Anderson, 336-436-5274
Copyright Business Wire 2009
